For a treatment choice the early identification of non-ST myocardial infarction segment patients
(NSTEMI) with poor in-hospital results is essential. The CHA2DS2-VASc-HS and CHA2DS2-VASc
score was recently reported as a predictor of severity and poor outcomes in individuals with stable
coronary artery disease (CAD) and acute coronary syndrome. Our research aimed at evaluating the
precision of the CHA2DS2-VASc-HS score, which predicts poor outcomes in hospitals in NSTEMI
patients. 120 NSTEMI patients have been enrolled. The score for CHA2DS2-VASc-HS has been
computed. The participants of the research were split into two groups. Group I and Group II score 4. Patients with CHA2DS2-VASc-HS >4
were found to have higher unfavourable outcomes in the hospital than the CHA2DS2-VASc-HS score
|
